{"id":"W4308260067","doi":"10.1038/s41416-022-02025-9","title":"A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer","year":2022,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Pfizer","keywords":"Tolerability; Medicine; Mucositis; Docetaxel; Internal medicine; Response Evaluation Criteria in Solid Tumors; Breast cancer; Triple-negative breast cancer; Oncology; Cancer; Phases of clinical research; Adverse effect; Gastroenterology; Chemotherapy; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003029935,0.0001789885,0.0004254466,0.00009627566,0.0001393643,0.00005424237,0.000340673,0.00004187217,0.00004689172],"category_scores_gemma":[0.00003354978,0.0001771146,0.00003304702,0.0002189148,0.0000785287,0.00005072006,0.0001207345,0.0002065016,3.235541e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001468598,"about_ca_system_score_gemma":0.0003811762,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001143708,"about_ca_topic_score_gemma":0.002838401,"domain_scores_codex":[0.9984255,0.0001363346,0.0004556925,0.0003204044,0.0004156677,0.0002464002],"domain_scores_gemma":[0.9983967,0.00002145049,0.0007761118,0.0001222559,0.0005955143,0.00008795586],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.05390061,0.05897875,0.6457976,0.0003007388,0.002451276,0.0002498141,0.002701302,0.009208588,0.05070352,0.00001426568,0.004532031,0.1711615],"study_design_scores_gemma":[0.5020479,0.04733992,0.4041786,0.001955247,0.0006406244,0.0006030829,0.003486422,0.0004095426,0.03359247,0.0000907939,0.004279405,0.001375997],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956478,0.001757289,0.00009641024,0.00006614575,0.0001985626,0.001196062,0.001018763,0.000002358671,0.00001657192],"genre_scores_gemma":[0.9986911,0.0003287451,0.0002838075,0.0001673172,0.00007117905,0.0003230009,0.00002226081,0.00005086973,0.00006165258],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4481473,"threshold_uncertainty_score":0.7222525,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01529950966336782,"score_gpt":0.3277349865391015,"score_spread":0.3124354768757337,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}